ID   UBP45_HUMAN             Reviewed;         814 AA.
AC   Q70EL2; B2RXG0; Q5T062; Q86T44; Q86TC0; Q9BRU1;
DT   20-MAR-2007, integrated into UniProtKB/Swiss-Prot.
DT   18-MAY-2010, sequence version 3.
DT   15-MAR-2017, entry version 115.
DE   RecName: Full=Ubiquitin carboxyl-terminal hydrolase 45;
DE            EC=3.4.19.12;
DE   AltName: Full=Deubiquitinating enzyme 45;
DE   AltName: Full=Ubiquitin thioesterase 45;
DE   AltName: Full=Ubiquitin-specific-processing protease 45;
GN   Name=USP45;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), CATALYTIC ACTIVITY, AND TISSUE
RP   SPECIFICITY.
RX   PubMed=14715245; DOI=10.1016/j.bbrc.2003.12.050;
RA   Quesada V., Diaz-Perales A., Gutierrez-Fernandez A., Garabaya C.,
RA   Cal S., Lopez-Otin C.;
RT   "Cloning and enzymatic analysis of 22 novel human ubiquitin-specific
RT   proteases.";
RL   Biochem. Biophys. Res. Commun. 314:54-62(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3), NUCLEOTIDE
RP   SEQUENCE [LARGE SCALE MRNA] OF 248-814 (ISOFORM 1), AND VARIANT
RP   SER-778.
RC   TISSUE=Skeletal muscle;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E.,
RA   Gilbert J.G.R., Clamp M.E., Bethel G., Milne S., Ainscough R.,
RA   Almeida J.P., Ambrose K.D., Andrews T.D., Ashwell R.I.S.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Banerjee R., Barker D.J.,
RA   Barlow K.F., Bates K., Beare D.M., Beasley H., Beasley O., Bird C.P.,
RA   Blakey S.E., Bray-Allen S., Brook J., Brown A.J., Brown J.Y.,
RA   Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E.,
RA   Ellington A.E., Evans K.A., Faulkner L., Francis M.D., Frankish A.,
RA   Frankland J., French L., Garner P., Garnett J., Ghori M.J.,
RA   Gilby L.M., Gillson C.J., Glithero R.J., Grafham D.V., Grant M.,
RA   Gribble S., Griffiths C., Griffiths M.N.D., Hall R., Halls K.S.,
RA   Hammond S., Harley J.L., Hart E.A., Heath P.D., Heathcott R.,
RA   Holmes S.J., Howden P.J., Howe K.L., Howell G.R., Huckle E.,
RA   Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M., Joy A.A.,
RA   Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R., Lloyd D.M.,
RA   Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K.,
RA   McMurray A., Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T.,
RA   Novik K.L., Oliver K., Overton-Larty E.K., Parker A., Patel R.,
RA   Pearce A.V., Peck A.I., Phillimore B.J.C.T., Phillips S., Plumb R.W.,
RA   Porter K.M., Ramsey Y., Ranby S.A., Rice C.M., Ross M.T., Searle S.M.,
RA   Sehra H.K., Sheridan E., Skuce C.D., Smith S., Smith M., Spraggon L.,
RA   Squares S.L., Steward C.A., Sycamore N., Tamlyn-Hall G., Tester J.,
RA   Theaker A.J., Thomas D.W., Thorpe A., Tracey A., Tromans A., Tubby B.,
RA   Wall M., Wallis J.M., West A.P., White S.S., Whitehead S.L.,
RA   Whittaker H., Wild A., Willey D.J., Wilmer T.E., Wood J.M., Wray P.W.,
RA   Wyatt J.C., Young L., Younger R.M., Bentley D.R., Coulson A.,
RA   Durbin R.M., Hubbard T., Sulston J.E., Dunham I., Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2), AND
RP   VARIANTS GLU-67; THR-521 AND SER-778.
RC   TISSUE=Bone marrow, and Brain cortex;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
CC   -!- CATALYTIC ACTIVITY: Thiol-dependent hydrolysis of ester,
CC       thioester, amide, peptide and isopeptide bonds formed by the C-
CC       terminal Gly of ubiquitin (a 76-residue protein attached to
CC       proteins as an intracellular targeting signal).
CC       {ECO:0000269|PubMed:14715245}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q70EL2-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q70EL2-2; Sequence=VSP_023791, VSP_023792;
CC         Note=No experimental confirmation available.;
CC       Name=3;
CC         IsoId=Q70EL2-3; Sequence=VSP_023789, VSP_023790, VSP_023793;
CC         Note=May be produced at very low levels due to a premature stop
CC         codon in the mRNA, leading to nonsense-mediated mRNA decay. No
CC         experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Broadly expressed, with highest levels in
CC       ovary, skeletal muscle and spleen. {ECO:0000269|PubMed:14715245}.
CC   -!- SIMILARITY: Belongs to the peptidase C19 family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=CAI17192.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC       Sequence=CAI19761.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AJ583819; CAE47746.2; -; mRNA.
DR   EMBL; AL713747; CAD89915.1; -; mRNA.
DR   EMBL; AL832030; CAD91148.1; -; mRNA.
DR   EMBL; AL513550; CAI17192.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; AL137784; CAI17192.1; JOINED; Genomic_DNA.
DR   EMBL; AL137784; CAI19761.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; AL513550; CAI19761.1; JOINED; Genomic_DNA.
DR   EMBL; BC005991; AAH05991.1; -; mRNA.
DR   EMBL; BC150648; AAI50649.1; -; mRNA.
DR   EMBL; BC157838; AAI57839.1; -; mRNA.
DR   CCDS; CCDS34501.1; -. [Q70EL2-1]
DR   RefSeq; NP_001073950.1; NM_001080481.1. [Q70EL2-1]
DR   RefSeq; NP_001332950.1; NM_001346021.1. [Q70EL2-1]
DR   RefSeq; NP_001332951.1; NM_001346022.1. [Q70EL2-1]
DR   RefSeq; XP_005267227.1; XM_005267170.4. [Q70EL2-1]
DR   UniGene; Hs.143410; -.
DR   UniGene; Hs.677065; -.
DR   ProteinModelPortal; Q70EL2; -.
DR   BioGrid; 124430; 30.
DR   IntAct; Q70EL2; 27.
DR   STRING; 9606.ENSP00000333376; -.
DR   MEROPS; C19.064; -.
DR   iPTMnet; Q70EL2; -.
DR   PhosphoSitePlus; Q70EL2; -.
DR   BioMuta; USP45; -.
DR   DMDM; 296453002; -.
DR   EPD; Q70EL2; -.
DR   MaxQB; Q70EL2; -.
DR   PaxDb; Q70EL2; -.
DR   PeptideAtlas; Q70EL2; -.
DR   PRIDE; Q70EL2; -.
DR   DNASU; 85015; -.
DR   Ensembl; ENST00000327681; ENSP00000333376; ENSG00000123552. [Q70EL2-1]
DR   Ensembl; ENST00000500704; ENSP00000424372; ENSG00000123552. [Q70EL2-1]
DR   GeneID; 85015; -.
DR   KEGG; hsa:85015; -.
DR   UCSC; uc003ppx.4; human. [Q70EL2-1]
DR   CTD; 85015; -.
DR   GeneCards; USP45; -.
DR   H-InvDB; HIX0006090; -.
DR   HGNC; HGNC:20080; USP45.
DR   HPA; HPA029602; -.
DR   HPA; HPA029604; -.
DR   neXtProt; NX_Q70EL2; -.
DR   OpenTargets; ENSG00000123552; -.
DR   PharmGKB; PA134889604; -.
DR   eggNOG; KOG1873; Eukaryota.
DR   eggNOG; COG5560; LUCA.
DR   GeneTree; ENSGT00860000133682; -.
DR   HOGENOM; HOG000154755; -.
DR   HOVERGEN; HBG062704; -.
DR   InParanoid; Q70EL2; -.
DR   KO; K11844; -.
DR   OMA; KCETDEI; -.
DR   OrthoDB; EOG091G01WT; -.
DR   PhylomeDB; Q70EL2; -.
DR   TreeFam; TF326075; -.
DR   Reactome; R-HSA-5696395; Formation of Incision Complex in GG-NER.
DR   ChiTaRS; USP45; human.
DR   GenomeRNAi; 85015; -.
DR   PRO; PR:Q70EL2; -.
DR   Proteomes; UP000005640; Chromosome 6.
DR   Bgee; ENSG00000123552; -.
DR   CleanEx; HS_USP45; -.
DR   ExpressionAtlas; Q70EL2; baseline and differential.
DR   Genevisible; Q70EL2; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:MGI.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0005634; C:nucleus; IDA:MGI.
DR   GO; GO:0004843; F:thiol-dependent ubiquitin-specific protease activity; IDA:FlyBase.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:0006281; P:DNA repair; IMP:MGI.
DR   GO; GO:0070911; P:global genome nucleotide-excision repair; TAS:Reactome.
DR   GO; GO:0016579; P:protein deubiquitination; IDA:FlyBase.
DR   GO; GO:0006511; P:ubiquitin-dependent protein catabolic process; IEA:InterPro.
DR   Gene3D; 3.30.40.10; -; 1.
DR   InterPro; IPR001394; Peptidase_C19_UCH.
DR   InterPro; IPR018200; USP_CS.
DR   InterPro; IPR028889; USP_dom.
DR   InterPro; IPR013083; Znf_RING/FYVE/PHD.
DR   InterPro; IPR001607; Znf_UBP.
DR   Pfam; PF00443; UCH; 1.
DR   Pfam; PF02148; zf-UBP; 1.
DR   PROSITE; PS00972; USP_1; 1.
DR   PROSITE; PS00973; USP_2; 1.
DR   PROSITE; PS50235; USP_3; 1.
DR   PROSITE; PS50271; ZF_UBP; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Complete proteome; Hydrolase; Metal-binding;
KW   Phosphoprotein; Polymorphism; Protease; Reference proteome;
KW   Thiol protease; Ubl conjugation pathway; Zinc; Zinc-finger.
FT   CHAIN         1    814       Ubiquitin carboxyl-terminal hydrolase 45.
FT                                /FTId=PRO_0000280561.
FT   DOMAIN      190    813       USP.
FT   ZN_FING      60    136       UBP-type. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00502}.
FT   ACT_SITE    199    199       Nucleophile. {ECO:0000255|PROSITE-
FT                                ProRule:PRU10092, ECO:0000255|PROSITE-
FT                                ProRule:PRU10093}.
FT   ACT_SITE    746    746       Proton acceptor. {ECO:0000255|PROSITE-
FT                                ProRule:PRU10092, ECO:0000255|PROSITE-
FT                                ProRule:PRU10093}.
FT   MOD_RES      28     28       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q8K387}.
FT   MOD_RES      29     29       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q8K387}.
FT   MOD_RES     508    508       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q8K387}.
FT   MOD_RES     526    526       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:Q8K387}.
FT   VAR_SEQ       1    262       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:17974005}.
FT                                /FTId=VSP_023789.
FT   VAR_SEQ     263    282       KETEKGPLSPKVLFNQLCQK -> MRSKKVVQNSRFFLPQT
FT                                LSW (in isoform 3).
FT                                {ECO:0000303|PubMed:17974005}.
FT                                /FTId=VSP_023790.
FT   VAR_SEQ     283    289       APRFKDF -> RVHLHLI (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_023791.
FT   VAR_SEQ     290    814       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_023792.
FT   VAR_SEQ     312    369       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:17974005}.
FT                                /FTId=VSP_023793.
FT   VARIANT      67     67       K -> E (in dbSNP:rs7744845).
FT                                {ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_031167.
FT   VARIANT     521    521       R -> T (in dbSNP:rs41288947).
FT                                {ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_060663.
FT   VARIANT     778    778       N -> S (in dbSNP:rs6570065).
FT                                {ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|PubMed:17974005}.
FT                                /FTId=VAR_031168.
FT   CONFLICT    603    603       A -> V (in Ref. 2; CAD91148).
FT                                {ECO:0000305}.
FT   CONFLICT    691    691       Q -> K (in Ref. 1; CAE47746).
FT                                {ECO:0000305}.
FT   CONFLICT    726    726       D -> G (in Ref. 2; CAD89915).
FT                                {ECO:0000305}.
SQ   SEQUENCE   814 AA;  91733 MW;  DE4FCC0AD7AD6499 CRC64;
     MRVKDPTKAL PEKAKRSKRP TVPHDEDSSD DIAVGLTCQH VSHAISVNHV KRAIAENLWS
     VCSECLKERR FYDGQLVLTS DIWLCLKCGF QGCGKNSESQ HSLKHFKSSR TEPHCIIINL
     STWIIWCYEC DEKLSTHCNK KVLAQIVDFL QKHASKTQTS AFSRIMKLCE EKCETDEIQK
     GGKCRNLSVR GITNLGNTCF FNAVMQNLAQ TYTLTDLMNE IKESSTKLKI FPSSDSQLDP
     LVVELSRPGP LTSALFLFLH SMKETEKGPL SPKVLFNQLC QKAPRFKDFQ QQDSQELLHY
     LLDAVRTEET KRIQASILKA FNNPTTKTAD DETRKKVKAY GKEGVKMNFI DRIFIGELTS
     TVMCEECANI STVKDPFIDI SLPIIEERVS KPLLWGRMNK YRSLRETDHD RYSGNVTIEN
     IHQPRAAKKH SSSKDKSQLI HDRKCIRKLS SGETVTYQKN ENLEMNGDSL MFASLMNSES
     RLNESPTDDS EKEASHSESN VDADSEPSES ESASKQTGLF RSSSGSGVQP DGPLYPLSAG
     KLLYTKETDS GDKEMAEAIS ELRLSSTVTG DQDFDRENQP LNISNNLCFL EGKHLRSYSP
     QNAFQTLSQS YITTSKECSI QSCLYQFTSM ELLMGNNKLL CENCTKNKQK YQEETSFAEK
     KVEGVYTNAR KQLLISAVPA VLILHLKRFH QAGLSLRKVN RHVDFPLMLD LAPFCSATCK
     NASVGDKVLY GLYGIVEHSG SMREGHYTAY VKVRTPSRKL SEHNTKKKNV PGLKAADNES
     AGQWVHVSDT YLQVVPESRA LSAQAYLLFY ERVL
//
